Gilead’s Lenacapavir Access Strategy in R...

By João L. Carapinha

October 14, 2024

Gilead Sciences, Inc. has announced important initiatives to increase access to lenacapavir, a potentially transformative HIV medication
Iraq Roche Partnership to Enhance Healthcare Services
Strategies to Control Rising Health Insurance Premiums in Singapore
FDA’s Opdivo Lung Cancer Approval
Mental Healthcare for Youth: Addressing Substance Use and Chronic Conditions
NICE Collaborates with Menarini to Evaluate Elacestrant Breast Cancer Treatment
Depression and Life Satisfaction in Pregnant Women
The VA’s Journey with Early Adoption of AI in Healthcare
Enhancing Global Health through Regulatory Collaboration
Enhancing Child Mental Health Services with Digital Interventions
Strategic Phased Launch of Tirzepatide for Obesity Treatment in England
Mental Health Trends Among US Youths: Rising Prevalence of Depression and Anx...
The Trump Drug Policy Change: A Reverse Course